R. Kent McGaughy Jr., Director, 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 15,078 shares at $22.05 ($324K) on 2016-12-15, disclosed to the SEC on 2016-12-16.
Open-market purchase of $324k RETA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.37 | 6,189 | $132K | 40.8% |
| 2 | $21.37 | 6,189 | $132K | 40.8% |
| 3 | $22.05 | 2,700 | $60K | 18.4% |
| Total | $21.49 avg | 15,078 | $324K | 100% |
| Filing → |
| TIL | BUY | 2021-03-25 | $9.0M | — | Filing → |
| APEN | BUY | 2020-07-21 | $2.2M | — | Filing → |
| RETA | BUY | 2019-11-18 | $7.4M | — | Filing → |